Dermoscopic Response Predictors in Papulopustular Rosacea Treated with Topical Ivermectin and Metronidazole: A Prospective Observational Comparative Study.
randomized
EVIDENCE COMPARISON
SupportiveIvermectin
vs Metronidazole
for Redness Reduction
Early evidence suggests ivermectin reduces redness approximately 1.4 times more effectively than metronidazole, supporting better skin tone outcomes in rosacea.
1.40x
Effect ratio
Ivermectin
Favored
1
Study
Direct
Comparison
ExploratorySubjective endpointTone
Limits: Supportive evidence tier · Includes subjective endpoint · Estimated effect size
How to read this claim
Published as an exploratory public claim: direct comparison with exact provenance, but with limits noted for supportive evidence tier, includes subjective endpoint, estimated effect size.
The underlying trial context suggests this comparison may not generalize cleanly beyond the specific tested formulations.
Upstream study enrichment was not enabled for this export, so formulation-specific trial context may be incomplete here.